Published in Proc Natl Acad Sci U S A on October 01, 1982
Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol (1987) 8.81
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol (1990) 7.90
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol (1989) 6.11
A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J (1990) 5.74
Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J Virol (1985) 5.21
Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol Cell Biol (1983) 4.96
Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J Virol (1988) 4.88
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus. Proc Natl Acad Sci U S A (1984) 4.81
Bacterial beta-galactosidase as a marker of Rous sarcoma virus gene expression and replication. Mol Cell Biol (1985) 4.41
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
Amphotropic retrovirus vector system for human cell gene transfer. Mol Cell Biol (1984) 4.16
A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging. J Virol (1986) 3.95
The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J Virol (1996) 3.91
High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57
RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1. J Virol (1995) 3.53
The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J Virol (1992) 3.48
cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus. J Virol (1983) 3.34
A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol (1990) 3.33
Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J Virol (1993) 3.15
Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J Virol (1991) 3.00
Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biochemical properties of mutant TK15 and mutant-induced transformants. J Virol (1984) 2.95
New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J Virol (1989) 2.86
Human immunodeficiency virus vectors for inducible expression of foreign genes. J Virol (1992) 2.70
Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. J Virol (1989) 2.69
Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J Virol (1994) 2.68
5'-terminal sequences influence the segregation of ground squirrel hepatitis virus RNAs into polyribosomes and viral core particles. J Virol (1987) 2.54
Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs. J Virol (1993) 2.52
Fragments from both termini of the herpes simplex virus type 1 genome contain signals required for the encapsidation of viral DNA. Nucleic Acids Res (1983) 2.37
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
Complete nucleotide sequence of an infectious clone of Friend spleen focus-forming provirus: gp55 is an envelope fusion glycoprotein. Proc Natl Acad Sci U S A (1983) 2.23
Specificity of retroviral RNA packaging. J Virol (1991) 2.22
Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J Virol (1993) 2.17
Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region. J Virol (1993) 2.15
Construction of a retrovirus capable of transducing and expressing genes in multipotential embryonic cells. Proc Natl Acad Sci U S A (1984) 2.15
A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A (1987) 2.13
v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J Virol (1988) 2.08
vRel is an inactive member of the Rel family of transcriptional activating proteins. J Virol (1991) 2.04
Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors. Proc Natl Acad Sci U S A (1984) 2.02
Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Mol Cell Biol (1989) 1.87
Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biological properties of mutant TK15 and mutant-induced transformants. J Virol (1984) 1.83
An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J Virol (1994) 1.81
Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant. J Virol (1990) 1.75
Retrovirus transduction: generation of infectious retroviruses expressing dominant and selectable genes is associated with in vivo recombination and deletion events. Mol Cell Biol (1983) 1.72
Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent. Nucleic Acids Res (1991) 1.61
Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably? Retrovirology (2004) 1.59
A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J (1994) 1.58
Molecular genetic characterization of the RD-114 gene family of endogenous feline retroviral sequences. J Virol (1984) 1.57
Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dimer of the 5'-terminal genomic RNA fragment. J Virol (1991) 1.52
Recombination of transfected DNAs in vertebrate cells in culture. Proc Natl Acad Sci U S A (1984) 1.50
Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine, and human retroviruses. J Virol (1993) 1.43
Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study. J Virol (1994) 1.42
Expression from an internal AUG codon of herpes simplex thymidine kinase gene inserted in a retrovirus vector. Mol Cell Biol (1984) 1.42
A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes. J Virol (1990) 1.38
The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains. Nucleic Acids Res (1992) 1.36
Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5' HIV-1 genomic RNA sequence. J Virol (1996) 1.36
Unusual features of the leader sequence of Rous sarcoma virus packaging mutant TK15. J Virol (1985) 1.32
E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J Virol (1995) 1.32
Lentiviral vectors in gene therapy: their current status and future potential. Arch Immunol Ther Exp (Warsz) (2010) 1.29
A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel. Mol Cell Biol (1991) 1.29
The location of v-src in a retrovirus vector determines whether the virus is toxic or transforming. Mol Cell Biol (1984) 1.24
The leading sequence of caulimovirus large RNA can be folded into a large stem-loop structure. Nucleic Acids Res (1988) 1.18
trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1. J Virol (1996) 1.17
Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc Natl Acad Sci U S A (1986) 1.16
Sequences in pol are required for transfer of human foamy virus-based vectors. J Virol (1998) 1.15
Pseudotyped retroviral vectors reveal restrictions to reticuloendotheliosis virus replication in rat cells. J Virol (1986) 1.12
The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag gene. J Virol (1995) 1.11
Molecular cloning and characterization of the RNA packaging-defective retrovirus SE21Q1b. J Virol (1992) 1.09
Retroviral characteristics of the long terminal repeat of murine E.Tn sequences. EMBO J (1985) 1.09
Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retroviruses. J Virol (1995) 1.09
A novel retroviruslike family in mouse DNA. J Virol (1986) 1.08
An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles. J Virol (1999) 1.07
cis-Acting sequences required for simian foamy virus type 1 vectors. J Virol (1998) 1.04
Generation of a helper cell line for packaging avian leukosis virus-based vectors. J Virol (1989) 1.01
Fluidity of a retrovirus genome. J Virol (1984) 0.95
Characterization of a myc-containing retrovirus generated by propagation of an MH2 viral subgenomic RNA. J Virol (1986) 0.95
Transcription from a spleen necrosis virus 5' long terminal repeat is suppressed in mouse cells. J Virol (1987) 0.95
Structure and transforming function of transduced mutant alleles of the chicken c-myc gene. J Virol (1986) 0.93
Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus. Proc Natl Acad Sci U S A (1987) 0.93
cis-Acting elements important for retroviral RNA packaging specificity. J Virol (2002) 0.92
Replication-defective vectors of reticuloendotheliosis virus transduce exogenous genes into somatic stem cells of the unincubated chicken embryo. J Virol (1989) 0.92
Gammaretroviral vectors: biology, technology and application. Viruses (2011) 0.91
The bovine leukemia virus encapsidation signal is composed of RNA secondary structures. J Virol (1998) 0.91
p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells. Nucleic Acids Res (1993) 0.86
Structural dynamics of retroviral genome and the packaging. Front Microbiol (2011) 0.83
Retroviral and lentiviral vectors for the induction of immunological tolerance. Scientifica (Cairo) (2012) 0.80
Cross- and Co-Packaging of Retroviral RNAs and Their Consequences. Viruses (2016) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Stimulation by cyclic adenosine monophosphate of plasmid deoxyribonucleic acid replication and catabolite repression of the plasmid deoxyribonucleic acid-protein relaxation complex. J Bacteriol (1973) 30.43
A precursor of globin messenger RNA. J Mol Biol (1976) 5.34
Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: characterization of a deletion in the provirus. J Virol (1980) 4.77
An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell (1978) 4.66
Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell (1981) 3.80
Mechanisms and applications of DNA-mediated gene transfer in mammalian cells - a review. Gene (1981) 3.46
Assembly of the particle of tobacco mosaic virus from RNA and disks of protein. Nat New Biol (1971) 2.94
Bacteriophage lambda derivatives carrying two copies of the cohesive end site. J Mol Biol (1974) 2.93
Early events in the in vitro packaging of bacteriophage lambda DNA. Virology (1977) 2.47
The genome-associated, specific RNA binding proteins of avian and mammalian type C viruses. Cell (1977) 2.42
Infectious and noninfectious recombinant clones of the provirus of SNV differ in cellular DNA and are apparently the same in viral DNA. Cell (1980) 2.35
Rous sarcoma virus p19 binds to specific double-stranded regions of viral RNA: effect of p19 on cleavage of viral RNA by RNase III. Virology (1978) 2.26
Spontaneous changes in nucleotide sequence in proviruses of spleen necrosis virus, an avian retrovirus. Proc Natl Acad Sci U S A (1982) 2.16
Properties of the avian viral protein p12. J Gen Virol (1981) 1.90
Evidence for polar reconstitution of TMV. FEBS Lett (1971) 1.28
Duplication of the bacteriophage lambda cohesive end site: genetic studies. J Mol Biol (1974) 1.23
Polar reconstitution of tobacco mosaic virus (TMV). Virology (1971) 1.22
Specificity of in vitro binding of primate Type C viral RNA and the homologous viral p12 core protein. Science (1976) 1.20
[Influence of phosphodiesterase of swine spleen on the reconstitution in vitro of tobacco mosaic virus]. C R Acad Sci Hebd Seances Acad Sci D (1971) 1.18
Chromosome-mediated gene transfer in mammalian cells. Annu Rev Genet (1980) 1.15
RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (1970) 19.89
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem (1987) 10.61
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02
Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol (1991) 8.77
Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66
Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci (1995) 6.36
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
Retroviral recombination and reverse transcription. Science (1990) 6.27
RNA-directed DNA synthesis and RNA tumor viruses. Adv Virus Res (1972) 6.11
Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays. Proc Natl Acad Sci U S A (2001) 6.07
Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature (1980) 5.95
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol Cell Biol (1983) 4.96
Structure, variation and synthesis of retrovirus long terminal repeat. Cell (1981) 4.90
The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature (1984) 4.89
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus. Proc Natl Acad Sci U S A (1984) 4.81
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci U S A (1990) 4.72
Studies on carcinogenesis by avian sarcoma viruses. VI. Differential multiplication of uninfected and of converted cells in response to insulin. J Cell Physiol (1967) 4.55
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 4.39
Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (1984) 4.29
Mechanism of cell transformation by RNA tumor viruses. Annu Rev Microbiol (1971) 4.24
Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel. J Virol (1984) 4.17
Carcinogenesis by RNA sarcoma viruses. XII. A quantitative study of infection of rat cells in vitro by avian sarcoma viruses. Virology (1970) 3.90
Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell (1981) 3.80
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Origin of retroviruses from cellular moveable genetic elements. Cell (1980) 3.67
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain (2007) 3.64
Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity. J Virol (1973) 3.62
High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57
Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus. J Virol (1980) 3.53
Circles with two tandem LTRs are precursors to integrated retrovirus DNA. Cell (1984) 3.45
Stimulation by serum of multiplication of stationary chicken cells. J Cell Physiol (1971) 3.41
Cell cycle-dependent activation of rous sarcoma virus-infected stationary chicken cells: avian leukosis virus group-specific antigens and ribonucleic acid. J Virol (1972) 3.35
A DNA-depenent DNA polymerase and a DNA endonuclease in virions of Rous sarcoma virus. Nature (1970) 3.31
Formation and structure of infectious DNA of spleen necrosis virus. J Virol (1977) 3.29
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
Replication of reticuloendotheliosis viruses in cell culture: acute infection. J Virol (1974) 3.17
High-efficiency ligation and recombination of DNA fragments by vertebrate cells. Science (1983) 2.99
Comparison of Rous sarcoma virus-specific deoxyribonucleic acid polymerases in virions of Rous sarcoma virus and in Rous sarcoma virus-infected chicken cells. J Virol (1971) 2.97
Function of the retrovirus long terminal repeat. Cell (1982) 2.89
Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol (1988) 2.88
New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J Virol (1989) 2.86
Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA. J Virol (1974) 2.86
Infectious rous sarcoma virus and reticuloendotheliosis virus DNAs. J Virol (1974) 2.77
Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology (1984) 2.75
Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J Virol (1977) 2.71
Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis (2001) 2.66
Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science (1993) 2.64
Reticuloendotheliosis virus nucleic acid sequences in cellular DNA. J Virol (1974) 2.55
Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut (1999) 2.51
Characterization of reticuloendotheliosis virus strain T DNA and isolation of a novel variant of reticuloendotheliosis virus strain T by molecular cloning. J Virol (1981) 2.49
Lack of serological relationship among DNA polymerases of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken cells. J Virol (1973) 2.46
Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation (2000) 2.42
Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41
Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector. Nature (1982) 2.38
The partial purification from calf serum of a fraction with multiplication-stimulating activity for chicken fibroblasts in cell culture and with non-suppressible insulin-like activity. J Cell Physiol (1972) 2.37
Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int (2006) 2.37
Infectious and noninfectious recombinant clones of the provirus of SNV differ in cellular DNA and are apparently the same in viral DNA. Cell (1980) 2.35
Genetic basis of the neurovirulence of pseudorabies virus. J Virol (1984) 2.34
The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons. Nat Genet (1995) 2.34
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
Enhancement of enterotoxin production by carbon dioxide in Vibrio cholerae. Infect Immun (1985) 2.34
Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33
Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J Virol (1979) 2.33
The DNA provirus hypothesis. Science (1976) 2.31
Primary structure of AUA-specific isoleucine transfer ribonucleic acid from Escherichia coli. Biochemistry (1980) 2.29
Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28
Establishment of infection by spleen necrosis virus: inhibition in stationary cells and the role of secondary infection. J Virol (1982) 2.26
Studies on carcinogenesis by avian sarcoma viruses. 8. Glycolysis and cell multiplication. Int J Cancer (1968) 2.25
Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr (2000) 2.24
The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol (1986) 2.19
Spontaneous changes in nucleotide sequence in proviruses of spleen necrosis virus, an avian retrovirus. Proc Natl Acad Sci U S A (1982) 2.16
A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A (1987) 2.13
Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol (2001) 2.13
Characterization of the immediate-early functions of pseudorabies virus. Virology (1983) 2.12
Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. Virology (1988) 2.11
Cell killing by avian leukosis viruses. J Virol (1981) 2.10
Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage (1996) 2.09
v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J Virol (1988) 2.08
Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol Cell Biol (1986) 2.08
Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. Aliment Pharmacol Ther (2013) 2.08
Structure and function of chicken gizzard myosin. J Biochem (1978) 2.05
5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J Virol (1992) 2.03
Light inactivation of focus formation by chicken embryo fibroblasts infected with avian sarcoma virus in the presence of 5-bromodeoxyuridine. Nature (1970) 2.02
Plasma concentrations of phyto-oestrogens in Japanese men. Lancet (1993) 2.01
Walking speed as a good predictor for the onset of functional dependence in a Japanese rural community population. Age Ageing (2000) 1.99
Lack of infectivity of the endogenous avian leukosis virus-related genes in the DNA of uninfected chicken cells. J Virol (1976) 1.99
Predictors for functional decline among nondisabled older Japanese living in a community during a 3-year follow-up. J Am Geriatr Soc (2000) 1.98
Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell (1986) 1.96
A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblasts. J Cell Physiol (1973) 1.93
The protovirus hypothesis: speculations on the significance of RNA-directed DNA synthesis for normal development and for carcinogenesis. J Natl Cancer Inst (1971) 1.93
Hybridization of Rous sarcoma virus deoxyribonucleic acid polymerase product and ribonucleic acids from chicken and rat cells infected with Rous sarcoma virus. J Virol (1972) 1.91
Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: a transient gene-integration marker for ES cells. Nucleic Acids Res (1998) 1.90
Inhibition of light- or glutamate-induced mPer1 expression represses the phase shifts into the mouse circadian locomotor and suprachiasmatic firing rhythms. J Neurosci (1999) 1.90
An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol (1982) 1.87
Multiplication-stimulating activity for chicken embryo fibroblasts from rat liver cell conditioned medium: a family of small polypeptides. J Cell Physiol (1973) 1.87
Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Mol Cell Biol (1989) 1.87